Cytochrome alkene epoxidation catalysis

In pursuit of biomimetic catalysts, metaUoporphyrins have been extensively studied in attempts to mimic the active site of cytochrome P450, which is an enzyme that catalyzes oxidation reactions in organisms. In recent decades, catalysis of alkene epoxidation with metaUoporphyrins has received considerable attention. It has been found that iron [1-3], manganese [4,5], chromium [6], and cobalt porphyrins can be used as model compounds for the active site of cytochrome P450, and oxidants such as iodosylbenzene, sodium hypochlorite [7,8], hydrogen peroxide [9], and peracetic acid [10] have been shown to work for these systems at ambient temperature and pressure. While researchers have learned a great deal about these catalysts, several practical issues limit their applicability, especially deactivation. 

Catalysis. Cytochrome P-450 model compounds catalyze the epoxidation of alkenes by hypochlorite ions.16 A typical catalyst is OMn(TMP)L+. 

In relation to enzymic cytochrome P-450 oxidations, catalysis by iron porphyrins has inspired many recent studies.659 663 The use of C6F5IO as oxidant and Fe(TDCPP)Cl as catalyst has resulted in a major improvement in both the yields and the turnover numbers of the epoxidation of alkenes. 59 The Michaelis-Menten kinetic rate, the higher reactivity of alkyl-substituted alkenes compared to that of aryl-substituted alkenes, and the strong inhibition by norbornene in competitive epoxidations suggested that the mechanism shown in Scheme 13 is heterolytic and presumably involves the reversible formation of a four-mernbered Fev-oxametallacyclobutane intermediate.660 Picket-fence porphyrin (TPiVPP)FeCl-imidazole, 02 and [H2+colloidal Pt supported on polyvinylpyrrolidone)] act as an artificial P-450 system in the epoxidation of alkenes.663... 

Many other redox reactions are potentially amenable to antibody catalysis. For example, the chemistry of the P-450 cytochromes, including the hydroxylation of alkanes and the epoxidation of alkenes, can be mimicked with synthetic porphyrins. Incorporation of such molecules into antibody active sites could conceivably yield new catalysts that combine the intrinsic reactivity of the cofactor with the tailored selectivity of the binding pocket. Work is just beginning in this area, but preliminary studies with porphyrin haptens have yielded some interesting results.126-130 Novel redox chemistry can also be anticipated for antibodies containing metal ions, flavins, nicotinamide analogs, and other reactive moieties. 

---